Subconjunctival 0.1% epinephrine versus placebo in maintenance of mydriasis during vitrectomy: a randomized controlled trial
- PMID: 30349740
- PMCID: PMC6192114
- DOI: 10.1186/s40942-018-0142-y
Subconjunctival 0.1% epinephrine versus placebo in maintenance of mydriasis during vitrectomy: a randomized controlled trial
Abstract
Background: Pupil dilation and mydriasis maintenance throughout vitreoretinal surgeries are important to allow satisfactory fundus visualization and reduce risk of complications. The purpose of this study is to evaluate the role of subconjunctival epinephrine 0.1% injection in mydriasis maintenance during vitrectomy.
Methods: Ninety-nine consecutive patients undergoing vitrectomy were enrolled. All subjects were preoperatively dilated with tropicamide 1%. Each patient was randomly allocated either in the epinephrine or placebo group. In epinephrine group, patients were submitted to a 0.2 cc subconjunctival injection of a 0.1% epinephrine solution just before first incisions. In placebo group, the same procedure was performed with 0.2 cc of saline 0.9%. Horizontal pupil diameter was measured with calipers before and in the end of the procedure.
Results: Patients in the epinephrine group showed a significantly larger mean pupil diameter in the end of the surgery compared to placebo. There was a significant increase of mean pupil diameter from the beginning to the end of the surgery in such patients. Blood pressure was significantly higher in the epinephrine group than in placebo group. No other adverse effects were noted.
Conclusion: Subconjunctival epinephrine is effective for maintaining and increasing pupil size during vitrectomy, compared to placebo. Caution should be taken regarding intraoperative blood pressure levels.
Trial registration: RBR; RBR-3qzhvg; Registered 8 May 2018-Retrospectively registered, http://www.ensaiosclinicos.gov.br/rg/RBR-3qzhvg/.
Keywords: Epinephrine; Mydriasis; Pupil; Vitrectomy.
Similar articles
-
The role of preoperative subconjunctival mydricaine and topical diclofenac sodium 0.1% in maintaining mydriasis during vitrectomy.Retina. 2000;20(1):46-51. doi: 10.1097/00006982-200001000-00009. Retina. 2000. PMID: 10696747 Clinical Trial.
-
Effect of topical nonsteroidal anti-inflammatory drugs and nuclear hardness on maintenance of mydriasis during phacoemulsification surgery.J Ocul Pharmacol Ther. 2014 Dec;30(10):831-6. doi: 10.1089/jop.2013.0244. J Ocul Pharmacol Ther. 2014. PMID: 25230350 Clinical Trial.
-
Maintenance of mydriasis with epinephrine during cataract surgery.Ophthalmic Surg. 1983 Jan;14(1):41-5. Ophthalmic Surg. 1983. PMID: 6828297
-
Effect of preoperative use of topical prednisolone acetate, ketorolac tromethamine, nepafenac and placebo, on the maintenance of intraoperative mydriasis during cataract surgery: a randomized trial.Indian J Ophthalmol. 2012 Jul;60(4):277-81. doi: 10.4103/0301-4738.98705. Indian J Ophthalmol. 2012. PMID: 22824596 Free PMC article. Clinical Trial.
-
Alternative mydriasis techniques for retinopathy of prematurity screening.Int Ophthalmol. 2020 Dec;40(12):3613-3619. doi: 10.1007/s10792-020-01542-x. Epub 2020 Aug 9. Int Ophthalmol. 2020. PMID: 32772218 Review.
Cited by
-
Ethanolic Extracts of Cupressaceae Species Conifers Provide Rapid Protection against Barium Chloride-Induced Cardiac Arrhythmia.Pharmaceuticals (Basel). 2024 Jul 29;17(8):1003. doi: 10.3390/ph17081003. Pharmaceuticals (Basel). 2024. PMID: 39204108 Free PMC article.
-
Urrets-Zavalia syndrome following placement of scleral-sutured intraocular lens.Am J Ophthalmol Case Rep. 2024 Feb 9;34:102010. doi: 10.1016/j.ajoc.2024.102010. eCollection 2024 Jun. Am J Ophthalmol Case Rep. 2024. PMID: 38384736 Free PMC article.
References
LinkOut - more resources
Full Text Sources